Readiness quiz
Identify the evidence gaps to close before choosing a partner.

Evidence before commitment.
15 questions. Five mandatory gates. Keep the evidence beside the answer.
Do you know what the clinic controls and who pays?
Evidence to show: a one-page responsibility and money-flow map, with a named budget owner.
Read the full question →An evidence hold is a procurement triage result—not a finding that a supplier has acted unlawfully. For an existing arrangement, escalate promptly to the appropriate clinical and legal owners; the quiz is not an instruction to abruptly interrupt patient treatment.
Answers stay in this session unless you choose to save. No account needed.
Read the research
Are you ready to choose, renew or replace a GLP-1 supply arrangement?
Answer these 15 questions to identify whether your next step should be route clarification, supplier diligence, commercial comparison or controlled implementation.
Read →What should you know before taking the quiz?
Assess the exact arrangement—not a supplier’s brand name or an entire clinic network at once.
Read →1. Do you know what the clinic controls and who pays?
Assess whether procurement is targeting an actionable decision rather than treating all patient medicine expenditure as clinic spend.
Read →2. Has the exact supply route received product-specific review? — MANDATORY GATE
A pharmacy licence, patient-specific prescription or 503B registration is not the complete route assessment.
Read →3. Have you verified the actual entities and destination-state permissions? — MANDATORY GATE
Verify the dispensing or supplying facility, not just the platform that introduced it.
Read →4. Can your team substantiate product provenance and assess quality evidence? — MANDATORY GATE
Treat identity, inspection evidence and product sourcing as separate checks.
Read →5. Are handling, administration information and safety escalation controlled? — MANDATORY GATE
Assess the handoffs where product or presentation changes could create confusion.
Read →6. Have you compared branded access and dispensing workflows—not just medicine prices?
Compare what each route requires the patient, clinic and pharmacy to do.
Read →7. Are the GLP-1 quotations genuinely comparable?
Normalize presentation, supply duration, eligibility and ongoing price before comparing totals.
Read →8. Can you calculate full cost per enrolled and successfully fulfilled patient-month?
Use a defined operating measure, not a claim of clinical success.
Read →9. Has capacity been tested against your actual demand?
Request capacity evidence for your product, presentation, states and order pattern—not a company-wide volume claim.
Read →10. Can you see and act on prescription failures before patients chase you?
Measure each fulfilment stage separately so that a dispatch promise does not conceal earlier delays.
Read →11. Is there an executable fallback if the main partner stops accepting orders?
A second supplier name is not a continuity plan.
Read →12. Have data-sharing roles and security controls been reviewed? — MANDATORY GATE
Determine the parties’ actual roles before deciding which agreements are required.
Read →13. Do the contract and programme terms bound your financial exposure?
Test what happens when the arrangement changes, not just what happens when it works.
Read →14. Could you transition without losing track of prescriptions, payments or patients?
Make the transition plan specific enough for the operating team to execute.
Read →20 pages shown
What are the limitations of this quiz?
This assessment does not verify a named supplier, inspect a facility, establish capacity or provide a 50-state legal analysis.
Read →Sources
Primary sources below were reviewed for this research.
Read →Research quality self-assessment
The research’s own assessment; not an external rating.